DEL BOCCIO, PIERO
 Distribuzione geografica
Continente #
NA - Nord America 3.569
EU - Europa 3.553
AS - Asia 1.825
SA - Sud America 181
OC - Oceania 13
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 9.160
Nazione #
US - Stati Uniti d'America 3.528
IT - Italia 1.018
SG - Singapore 794
IE - Irlanda 605
CN - Cina 541
SE - Svezia 367
UA - Ucraina 346
GB - Regno Unito 308
DE - Germania 307
TR - Turchia 281
FR - Francia 183
BR - Brasile 161
FI - Finlandia 156
IN - India 103
RU - Federazione Russa 89
NL - Olanda 36
CZ - Repubblica Ceca 34
HK - Hong Kong 31
CA - Canada 26
BE - Belgio 24
PL - Polonia 23
VN - Vietnam 22
AT - Austria 19
AU - Australia 12
AE - Emirati Arabi Uniti 10
JP - Giappone 10
LT - Lituania 10
MX - Messico 10
ES - Italia 8
AR - Argentina 6
ZA - Sudafrica 6
VE - Venezuela 5
EU - Europa 4
IQ - Iraq 4
KR - Corea 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CL - Cile 3
DK - Danimarca 3
GR - Grecia 3
IR - Iran 3
PK - Pakistan 3
AM - Armenia 2
AZ - Azerbaigian 2
BD - Bangladesh 2
CH - Svizzera 2
CO - Colombia 2
EC - Ecuador 2
EG - Egitto 2
HN - Honduras 2
ID - Indonesia 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
UZ - Uzbekistan 2
AL - Albania 1
BG - Bulgaria 1
BS - Bahamas 1
CR - Costa Rica 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
TW - Taiwan 1
Totale 9.160
Città #
Chandler 672
Dublin 597
Singapore 568
Jacksonville 426
Chieti 233
Southend 216
Princeton 199
The Dalles 159
Pescara 158
Izmir 153
Ashburn 144
Nanjing 143
Munich 142
Santa Clara 139
Dearborn 138
Ann Arbor 89
Beijing 89
Altamura 88
Wilmington 88
Boardman 76
New York 69
Helsinki 68
Cambridge 64
Rome 63
Nanchang 57
Los Angeles 43
Woodbridge 43
Hong Kong 29
Kunming 27
Shenyang 24
Brussels 23
Brno 22
Dong Ket 22
Hangzhou 19
Hebei 18
San Mateo 18
Tianjin 18
Washington 18
Nuremberg 17
Seattle 17
Guangzhou 16
São Paulo 16
Jiaxing 15
Kraków 15
Augusta 14
Amsterdam 13
Frankfurt am Main 13
L'aquila 13
Lappeenranta 13
London 13
Düsseldorf 12
Turku 12
Vienna 12
Grevenbroich 11
Milan 11
Norwalk 11
Teramo 11
Jinan 10
Olomouc 10
Tokyo 10
Toronto 10
Camerino 9
Redwood City 9
Bologna 8
Changsha 8
Pune 8
Sydney 8
Falls Church 7
Leawood 7
Roseto Degli Abruzzi 7
Ancona 6
Auburn Hills 6
Brooklyn 6
Houston 6
L’Aquila 6
Naples 6
Shanghai 6
West Jordan 6
Bangalore 5
Belo Horizonte 5
Boston 5
Charlotte 5
Chicago 5
Dubai 5
Edinburgh 5
Hanover 5
La Spezia 5
Montreal 5
Ottawa 5
Padova 5
San Vito Chietino 5
Verona 5
Zhengzhou 5
Aquila 4
Brescia 4
Council Bluffs 4
Guarulhos 4
Lanzhou 4
Moscow 4
Orange 4
Totale 5.679
Nome #
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients 293
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 155
Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis 137
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid 135
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs 135
Serum Lipidomic study reveals potential early biomarkers for predicting response to chemoradiotherapy in advanced rectal cancer: A pilot study 133
A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: application to RCC urinary exosomes 124
A lipidomic approach to the study of human CD4(+) T lymphocytes in multiple sclerosis. 121
Proteomic profiling of coronary thrombus in acute myocardial infarction 121
Extracellular vesicles and their potential use in monitoring cancer progression and therapy: The contribution of proteomics 120
Visible Photostability of Ruthenium and Platinum Phthalocyanines in Water and in the presence of Organic Substrates 119
Integration of metabolomics and proteomics in multiple sclerosis: from biomarkers discovery to personalized medicine 118
Advances in Lipidomics for Cancer Biomarkers Discovery 117
Cleavage of cystatin C is not associated with multiple sclerosis 117
Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action 115
Diabetic macroangiopathy: Pathogenetic insights and novel therapeutic approaches with focus on high glucose-mediated vascular damage 114
Development of a Rapid Mass Spectrometric Determination of AMP and Cyclic AMP for PDE3 Activity Study: Application and Computational Analysis for Evaluating the Effect of a Novel 2-oxo-1,2-dihydropyridine-3-carbonitrile Derivative as PDE-3 Inhibitor 111
UNRAVELING THE MOLECULAR REPERTOIRE OF TEARS AS A SOURCE OF BIOMARKERS: BEYOND OCULAR DISEASES 109
A computational platform for MALDI-TOF mass spectrometry data: Application to serum and plasma samples 109
Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cells. 108
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy 108
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 108
Proteomics characterization of protein adsorption onto hemodialysis membranes 106
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation 106
Neurodegenerative diseases as proteinopathies-driven immune disorders 106
Analytical assessment of MALDI-TOF Imaging Mass Spectrometry on thin histological samples. An insight in proteome investigation. 105
Tear Film Steroid Profiling in Dry Eye Disease by Liquid Chromatography Tandem Mass Spectrometry 105
Independent component analysis for the extraction of reliable protein signal profiles from MALDI-TOF mass spectra 102
AFFINITY AND SPECIFICITY OF ANTI-GM1 ANTIBODIES IN THE EXPERIMENTAL AXONAL MODEL OF GUILLAIN-BARRE SYNDROME 100
A proteomic approach for the characterization of C677T mutation of the human gene methylenetetrahydrofolate reductase. 99
ESI-MS in the study of the activity of alpha-chymotrypsin in aqueous surfactant media. 99
LIMPIC: a computational method for the separation of protein MALDI-TOF-MS signals from noise 99
Proteomics of thyroid fine-needle apiration: a promising approach for protein biomarker discovery 99
An Italian Innovative Small-Scale Approach to Promote the Conscious Consumption of Healthy Food 99
Protein expression profiling of Proteus mirabilis under chemical stress condition: A proteomic investigation without genome 97
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 97
Comparative proteome profiling of breast tumor cell lines by gel electrophoresis and mass spectrometry reveals an epithelial mesenchymal transition associated protein signature. 96
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 96
Stereoselective double reduction of 3-methyl-2-cyclohexenone by use of palladium and platinum nanoparticles in tandem with alcohol dehydrogenase 95
Oxidative degradation of cardiotoxic anticancer anthracyclines to phthalic acids. Novel function or ferrylmyoglobin. 92
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway 90
Liquid chromatography-tandem mass spectrometry analysis of oleuropein and its metabolite hydroxytyrosol in rat plasma and urine after oral administration. 89
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 89
Inhibition of de novo ceramide biosynthesis affects aging phenotype in an in vitro model of neuronal senescence 89
Glutathione transferases from Anguilla anguilla liver: identification, cloning and functional characterization. 88
extracellular vescicles as signaling mediators and disease biomarkers across biological barriers 87
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 86
Differential post-translational modifications of transthyretin in Alzheimer's disease: a study of the cerebral spinal fluid. 85
Characterization of oxidation end product of plasma albumin 'in vivo'. 85
Pre-analytical factors in clinical proteomics investigations: Impact of ex vivo protein modifications for multiple sclerosis biomarker discovery 85
Homo sapiens proteomics: clinical perspectives 84
Transitions of serum albumin in patients with glomerulosclerosis 'in vivo' characterization by electrophoretic titration curves. 84
Proteomic investigation in the detection of the illicit treatment of calves with growth-promoting agents. 84
Differential protein expression in tears of patients with primary open angle and pseudoexfoliative glaucoma 84
Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells. 84
Quantitative analysis of caffeic acid phenethyl ester in crude propolis by liquid chromatography-electrospray ionization mass spectrometry. 83
Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. 83
Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naïve to therapy. 83
Lo sviluppo di un confronto matematico per analisi differenziali di proteomica: applicazione ai profili MALDI-TOF-MS lineare. 83
A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines. 83
Cytotoxic and genotoxic effects of composite resins on cultured human gingival fibroblasts 83
BNT162b2 mRNA vaccination leads to long-term protection from COVID-19 disease 82
DIFFERENTIAL CEREBRO SPINAL FLUID PROTEOME INVESTIGATION OF LEBER HEREDITARY OPTIC NEUROPATHY (LHON) AND MULTIPLE SCLEROSIS. 81
Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation 79
Monospecific high-affinity and complement activating anti-GM1 antibodies are determinants in experimental axonal neuropathy 79
Repetitive Fragmentation Products of Albumin and {alpha}1-Antitrypsin in Glomerular Diseases Associated with Nephrotic Syndrome. 78
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 78
Clinical pharmacology of cyclooxygenase inhibition and pharmacodynamic interaction with aspirin by floctafenine in Thai healthy subjects. 77
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation" 77
Electrophoretic separations of cerebrospinal fluid proteins in clinical investigations. 76
Breast cancer in the era of integrating "Omics" approaches 76
Improving protein identification from linear MALDI-TOF spectra: validation of an automated tool for signal denoising and peak identification 75
Proteomic analysis of protein adsorption onto haemodialysis membranes 75
High-resolution 2-DE for resolving proteins, protein adducts and complexes in plasma. 75
Flow Cytometry Analysis of Circulating Extracellular Vesicle Subtypes from Fresh Peripheral Blood Samples 75
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 73
Proteomic investigations on differential post-translational modification of transthyretin in multiple sclerosis. 73
Proteins and protein fragments in nephrotic syndrome: Clusters, specificity and mechanisms 73
Targeted metabolomics detects a putatively diagnostic signature in plasma and dried blood spots from head and neck paraganglioma patients 72
Basophil Activation Test with Different Polyethylene Glycols in Patients with Suspected PEG Hypersensitivity Reactions 71
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 70
Validation of the GSP®/DELFIA® Anti-SARS-CoV-2 IgG Kit Using Dried Blood Samples for High-Throughput Serosurveillance and Standardized Quantitative Measurement of Anti-Spike S1 IgG Antibody Responses Post-Vaccination 69
Simulated hyperglycemia impairs insulin signaling in endothelial cells through a hyperosmolar mechanism 67
Sera mass spectrometry investigation in multiple sclerosis-affected patients 67
Phenotypic and proteomic analysis identifies hallmarks of blood circulating extracellular vesicles in NSCLC responders to immune checkpoint inhibitors 66
Ozone effect on the inflammatory and proteomic profile of human macrophages and airway epithelial cells 65
Biomarker investigations in neurodegenerative diseases 65
Multi-omics staging of locally advanced rectal cancer predicts treatment response: a pilot study 63
Analytical Evaluation of the Ideal Strategy for High-Throughput Flow Injection Analysis by Tandem Mass Spectrometry in Routine Newborn Screening 63
null 60
Fast LC–MS/MS screening method for the evaluation of drugs, illicit drugs, and other compounds in biological matrices 60
In vitro and in vivo lipidomics as a tool for probiotics evaluation 59
Tear proteomics reveals the molecular basis of the efficacy of human recombinant nerve growth factor treatment for Neurotrophic Keratopathy 59
Synthesis and Biological Evaluation of Novel Cinnamic Acid-Based Antimicrobials 59
Empagliflozin inhibits excessive autophagy through the AMPK/GSK3β signaling pathway in diabetic cardiomyopathy 54
Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis 53
Proteomic Investigation of the Role of Nucleostemin in Nucleophosmin-Mutated OCI-AML 3 Cell Line 53
Extracellular Vesicles in Regenerative Processes Associated with Muscle Injury Recovery of Professional Athletes Undergoing Sub Maximal Strength Rehabilitation 53
Anti-Obesity and Anti-Inflammatory Effects of Novel Carvacrol Derivatives on 3T3-L1 and WJ-MSCs Cells 52
Identification of an elongation factor 1Bγ protein with glutathione transferase activity in both yeast and mycelial morphologies from human pathogenic Blastoschizomyces capitatus 52
Totale 9.070
Categoria #
all - tutte 41.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.844


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202035 0 0 0 0 0 0 0 0 0 0 0 35
2020/2021717 86 14 97 28 53 127 24 15 109 69 40 55
2021/2022538 6 12 11 88 29 21 12 34 83 30 58 154
2022/20231.874 136 268 117 208 206 352 100 129 240 31 54 33
2023/20241.072 69 56 71 34 42 404 180 45 17 19 6 129
2024/20252.629 136 469 437 80 84 134 254 157 305 165 335 73
Totale 9.716